Td Waterhouse Canada Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Td Waterhouse Canada Inc.

$12.3 Trillion
Q3 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 4,293 shares of REGN stock, worth $3.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,293

Previous 4,706 8.78%

Holding current value

$3.2 Million

Previous $4.97 Billion 9.64%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $422,949 - $496,326	-413 Reduced 8.78%	4,293 $4.49 Billion
Q2 2024 Nov 12, 2024	BUY	$883.2 - $1071.19 $54,758 - $66,413	62 Added 1.34%	4,706 $4.97 Billion
Q2 2024 Aug 02, 2024	SELL	$883.2 - $1071.19 $145,728 - $176,746	-165 Reduced 3.43%	4,644 $5.89 Billion
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $795,269 - $875,141	881 Added 22.43%	4,809 $4.69 Billion
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $519,370 - $590,739	-670 Reduced 14.57%	3,928 $3.7 Billion
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $1.88 Million - $2.29 Million	2,709 Added 143.41%	4,598 $4.62 Billion
Q2 2023 Nov 13, 2023	BUY	$700.03 - $830.35 $52,502 - $62,276	75 Added 4.13%	1,889 $1.38 Billion
Q1 2023 Nov 13, 2023	SELL	$680.49 - $826.97 $55,119 - $66,984	-81 Reduced 4.27%	1,814 $1.52 Billion
Q4 2022 Nov 13, 2023	SELL	$705.89 - $766.39 $256,238 - $278,199	-363 Reduced 16.08%	1,895 $1.39 Billion
Q3 2022 Nov 13, 2023	BUY	$573.97 - $724.32 $312,239 - $394,030	544 Added 31.74%	2,258 $1.74 Billion
Q2 2022 Nov 13, 2023	BUY	$548.35 - $738.84 $31,255 - $42,113	57 Added 3.44%	1,714 $1.02 Billion
Q1 2022 Nov 13, 2023	BUY	$595.12 - $698.43 $61,892 - $72,636	104 Added 6.7%	1,657 $1.15 Billion
Q4 2021 Nov 13, 2023	BUY	$543.48 - $670.97 $844,024 - $1.04 Million	1,553 New	1,553 $961 Million

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Regeneron Pharmaceuticals, Inc. Transaction History